Pharmacological Interactions between the Dual Orexin Receptor Antagonist Daridorexant and Ethanol in a Double-Blind, Randomized, Placebo-Controlled, Double-Dummy, Four-Way Crossover Phase I Study in Healthy Subjects.
Benjamin BergerSander BrooksRob G J A ZuikerMuriel RichardClemens MuehlanJasper DingemansePublished in: CNS drugs (2020)
NCT03609775 (ClinicalTrials.gov Identifier).